Saint Luke’s Health System is committed to the health and safety of our patients, visitors, and staff. Effective Nov. 1, 2021, full COVID-19 vaccination is a condition of employment for all SLHS employees.

Dapagliflozin improved symptoms and physical limitations in patients with heart failure (HF) with preserved ejection fraction, according to results from the PRESERVED-HF trial.

"The treatment effect was large, clinically meaningful and statistically significant," Mikhail Kosiborod, MD, FACC, FAHA, cardiologist at Saint Luke's Mid America Heart Institute and professor of medicine at University of Missouri-Kansas City School of Medicine, said during a presentation at the Heart Failure Society of America Annual Scientific Meeting. He noted the results were consistent regardless of diabetes status and ejection fraction.  

Read the full Healio article: PRESERVED-HF: Dapagliflozin improves HFpEF symptoms at 12 weeks

Read more >

Related Content

Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more >
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more >
Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more >